HomeINDGN • NSE
add
Indegene Ltd
Nakaraang pagsara
₹566.25
Sakop ng araw
₹562.00 - ₹571.10
Sakop ng taon
₹499.00 - ₹736.30
Market cap
136.34B INR
Average na Volume
2.14M
P/E ratio
33.11
Dividend yield
0.35%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 7.56B | 12.28% |
Gastos sa pagpapatakbo | 5.66B | 4.76% |
Net na kita | 1.18B | 24.05% |
Net profit margin | 15.56 | 10.43% |
Kita sa bawat share | 4.88 | — |
EBITDA | 1.40B | 3.95% |
Aktuwal na % ng binabayarang buwis | 21.23% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 16.64B | 68.54% |
Kabuuang asset | 33.26B | 30.65% |
Kabuuang sagutin | 7.10B | -36.38% |
Kabuuang equity | 26.16B | — |
Natitirang share | 240.01M | — |
Presyo para makapag-book | 5.20 | — |
Return on assets | — | — |
Return on capital | 12.27% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.18B | 24.05% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
CEO
Itinatag
1998
Website
Mga Empleyado
4,158
